Like I said...I have a few shares. I bought some back it was around $0.50...then cost averaged down when it was around $0.28. Right now I have my focus on other things. Kinda waiting to see what will happen with the vote...but I am not not watching.

With this information posted, I just dont understand why people are still purchasing the stock. I know I have a few shares...but if I was on the outside looking to get in I would be waiting for the the vote. If it goes through they'll probably have plenty of opportunities to purchase shares lower than the current stock price.

I am a little worried about the proxy statement regarding the June 4th vote to dilute the stock 750M shares. I wonder what they plan on raising the money for...

what dont we know? share volume is up 250K, over the 65day avg, and it isnt even noon. it would be nice if the stock price reflected the demand.

Interesting. I am sure it doesn't matter but that is two days before their presentation at the Benzinga conference. If it were me, and the news was positive, I would want the information out sooner...you know, give it a little more time, than just a day or two, to be absorbed before presenting at an annual cannabis capital conference.

Right. Plus, unless the price is absolutely ridiculous, why would you sell your technology to one company when you could license it to them, and many others in the sector, and earn royalties...plus at the end of the day you still retain the rights to your technology.

I wouldn't mind tomorrow being the day that they release their revenue report.

Sooth and Randy, this stock has ticked over $5 since i have been in it. i am replying to the last time it happened because there was a conversation about it....around 1/25. the forum was excited about the growth except for one person who warned that when it would hit the $5 mark everyone would sell and it would fall back under $3. they warned that it seemed to be the norm with this stock, since they invested. surely enough, the second the stock hit the $5 mark it was like it fell off a cliff. do i hope that this time it is different...absolutely, because i think MRMDs strongest asset right now is their connection to GenCanna (hemp)....but i wont be surprised if history repeats itself.

My thoughts exactly!

I tried to refrain from replying...but I have a strong disdain for NBEV. I reviewed NBEV months ago when I wanted to add a hemp or CBD beverage company to my portfolio. IMO their mgmt is a sham. Since the farm bill they have touted products (Bob Marley/CBD) and possible partnerships (like Coca Cola) just to keep their stock a float. Their stock moves on emotion and "news" (hype). AND THIS NEWS IS NO DIFFERENT! Every article regarding this NBEV news reads as if NBEV was able to added Walmart as a distributor of their Bob Marley CBD beverages...WHEN THAT IS NOT THE CASE! Did they get into Walmart...yes...but read through and you will see it is for 3 of their Bob Marley Mate or non-CBD, caffeine boosted, drinks. The Walmart spokeswomen specifically stated that they have "NO PLANS TO CARRY THE CBD ITEM". Whoop-dee-doo... Will they get sales? Probably, because the name is cool, however I would rather invest in a company with proven products and probably the hardest working company in the last 6 months.

I am frustrated my Friday bid wasnt accepted even though the stock was at 2.22 for the last 15 mins of the day. I was hoping to get in at 2.25 today and that didn't happen. I know 2.50 is still an 'undervalued' price but I am wondering if I will have another chance at 2.25 or if those days are over.

Not MDCL...which I would recommend looking into.

What a bland day. I guess I shouldnt have expected much movement 1 week prior to their earnings report.

1990, I believe that you are correct. In an interview with Andy, he said that he expected the acquisition of MedPharm to complete in July....and Medicine Man Denver to occur in November.

https://www.fool.com/investing/2019/04/05/what-to-expect-from-aphria-on-apr-15.aspx

Cramer plays it safe. He wont push an OTC stock.

Additional Notes:
1. Shares have not been issued as of January 10, 2019
2. CLSH has 61,912,860 warrants outstanding with an average exercise price of US$0.53 and 575,000 restricted shares vesting between Dec. 1st, 2018 and Jun. 30th, 2019
3. Yorkville convertible at US$0.40, carries interest at 8.0% and matures Dec. 31st, 2019
4. Oasis note carries interest at 6.0% and matures Dec. 31st, 2019

Quick highlights:

*Las Vegas currently completing ~350 orders per day at an
average of $45; Aiming for ~500 orders
*Brockton completing ~225 orders per day at an average of
$125 (avg $300 for delivery); Targeting ~800-1,000 orders per day with
introduction of recreational sales

*Near-term expansion at Las Vegas to 6,600 lbs per year
*Near-term expansion at Brockton to 9,000 lbs per year
*New 86,000 sqft Leicester facility will add 28,000 lbs
annual flower capacity. CLSH will earn an 80% interest by funding $25M-
$30M construction capex. This investment provides an opportunity for CLSH to expand in Massachusetts cannabis market, currently realizing wholesale prices of ~$3,500/lb flower and ~$40/g oil equivalent


*CLSH plans to use ~35% of flower production as input for
production of oils, extracts and edibles
*Installation of CLSH proprietary extraction technology for the processing of up to ~12,600 lbs per year of flower and trim

*For both locations: Current revenue close to $1.0M per month
Capacity to reach $4-$5M per month for both medical and recreational

MARKET VALUE
Share price as of March 15 (OTCQB: CLSH) $0.39
Basic market capitalization $47,796,775
Cash balance $15,300,000
Note receivable $5,000,000
Debt outstanding $22,600,000
Enterprise value $44,320,000

There really werent any questions...so that ended quickly...but I was able to download the presentation before the live broadcast terminated.

Presenting right now...however it is on the Q&A section of the presentation.

https://www.prnewswire.com/news-releases/cls-holdings-usa-inc-to-webcast-live-at-virtualinvestorconferencescom-april-4th-300821648.html

I would think this is because the stock is at its 52 week high and most investors assume the stock will drop back down as opposed to breaking through.

As long as it isnt the Pixar movie, UP, where the old man dies.

All the executive staff have significant equity in the company. You want to know what I am hoping for?...I hope that MedPharm is sitting on research for some drug that the company doesn't want let known until after all three companies are rolled into one...and public. Then once that happens the will drop this bomb, apply for FDA approval...hopefully get it...and then BAM! the stock explodes.

Ok, so I will apply your same principles using the information found in the Spring 2019 investor presentation (on their website)...and assume $2.20 share price.

2018 Medicine Man Technologies revenue 9M

Projected 2019 Medicine Man Denver revenue 25M

Projected 2019 Combined companies between 40-50M

40/9 = 4.44 × 2.20 = 9.77
50/9 = 5.55 × 2.20 = 12.22

Same...opt for a YouTube channel. Most prefer videos...and I honestly think a video is an easier way to explain the intricacies of charting. Plus, with videos/subscribers, you might have the potential to earn more from advertising dollars than a book.

Knife, you should start a YouTube channel on how to read charts...

I am not a mathematician so I will probably get crucified for this answer...but share price is essentially Market cap divided by outstanding shares.

Currently on MarketWatch the Market Cap is 60.4M and the outstanding shares are 27.58M....divide them and you get approximately $2.19.

If you change the values to a market cap of 100M....and maintain the same outstanding shares you get $3.63

finally life...

Any idea why the stock hasn't updated since 12:50pm?

You talking GW? I would assume so because they have an FDA approved drug...that stock is too rich for my blood so I dont follow them. My previous comments were in regards to the Canadian companies, similar to Aphria, that are in the market.

Of course I hope for a positive report but let's face it, none of the other "top" cannabis companies had a positive revenue report...including CannTrust whom analysts reported as the most cash positive in the industry.

Therefore this is probably not going to be any different. These companies sell cannabis AND they all ran out of product within the first 4 days that it was legal in Canada. Since then they realized the potential of the industry and have been growing rapidly, i.e. spending money. Without product to offset the spending plus the opening of a new 800,000sqft facility...not to mention the the whole short selling incident...expect/prepare for it to be negative.

And by prepare, I mean, get the funds ready to invest because the industry will probably present itself yet another buying opportunity.

I have thought the same thing today regarding a few of the boards that we follow.

Thanks! Dang, you are quick!

We have all heard interviews from CEOs where they either decline to comment on future acquisitions or partnerships...or make sure that they phrase things in a way that does not raise any flags with the SEC. Granted I appreciate the openness of this company...but at the same time how are they allowed to broadcast it like it is a done deal without repercussions?

Also, how are they able to release this information especially when current law forbids the transaction from happening? Are they not misleading investors? What happens if Colorado doesn't sign House Bill 19-1090 into law?

Sooth, I am with you. Just been seeing this question over an over on several of the cannabis forums I follow. It seems like people are looking for excuses not to invest...or talk others out of investing. Everyone keeps questioning why American cannabis companies are not listed on NASDAQ or NYSE. When in reality, even if they wanted to, they cant.

By real exchange you mean NASDAQ or NYSE? If so, then when 1 of 2 things happen. (1) they quit the marijuana business in the U.S. or (2) marijuana becomes legal at the federal level.

So the theory is this...

Yes, they have the Nevada location that is less than a mile off the strip...but they also have an agreement with CanAssist, and can eventually own, In Good Health in Massachusetts. Due to the proximity to some of the major cities in the north east, and the dense population, Analysts project MA to have higher cannabis revenues than Colorado. In addition, the state only granted a few companies MJ licenses meaning, unlike Colorado, the competition within the MJ retail space is limited to only a handful of players.

MA has yet to be fully developed and CanAssist entered into a contract with a new 86,000 sqft grow facility expected to produce Q1 of 2020.

The stock is approx 40 cents...if you are willing to take the risk and are planning to hold long term I could easily see the current price doubling.


https://marijuanastocks.com/clsh-locks-up-joint-venture-agreement-with-cannassist/

Gotcha, thanks.

Bill, I read your post and first of all, thanks for the info. In general I agree with your conclusion however I disagree with your comments on selling the the rights to the technology. Chris Bunka has made it known that he DOES NOT want to sell the rights but liscense the tech and reap royalties. Yes, if all goes well Altria will have the ability to purchase the rights to their nicotine liscense in the United States, ONLY, but I assume that was negotiated because R&D is expensive. Lexaria can still liscense the tech to other nicotine companies globally. If testing is successful this technology is a goldmine! Keep in mind the original DehydraTECH patent expires in 2034, and if the tech is as amazing as we all hope, it will get knocked off by everyone.

Hopefully in November Medicine Man Technologies intends on incorporating MedPharm Holdings and Medicine Man Denver (4 retail outlets) under it's publicly held MDCL.

From what I gather based on House Bill 1090, current Colorado law doesn’t allow public investment in marijuana (i.e. marijuana retail locations).

MedPharm Holdings is a privately held (essentially) pharmaceutical company...and like Medicine Man, a consulting company, is not confined by this law.